Sanofi's Sarclisa approved in EU; COVID-19 pandemic to fuel FDA changes – Hahn
The European Commission approved Sarclisa for treating certain adults with a type of blood cancer; and the outbreak will accelerate policy changes regulators have long sought, U.S. Food and Drug Administration Commissioner Stephen Hahn said.
www.spglobal.com